CN103665068B - 一种1-N-乙基庆大霉素C1a的制备方法 - Google Patents
一种1-N-乙基庆大霉素C1a的制备方法 Download PDFInfo
- Publication number
- CN103665068B CN103665068B CN201310691184.6A CN201310691184A CN103665068B CN 103665068 B CN103665068 B CN 103665068B CN 201310691184 A CN201310691184 A CN 201310691184A CN 103665068 B CN103665068 B CN 103665068B
- Authority
- CN
- China
- Prior art keywords
- temperature
- gentamicinc
- preparation
- trichloromethane
- ethyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000034 method Methods 0.000 title abstract description 8
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims abstract description 39
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims abstract description 25
- 229960001701 chloroform Drugs 0.000 claims abstract description 19
- 239000000243 solution Substances 0.000 claims abstract description 17
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims abstract description 14
- 238000010790 dilution Methods 0.000 claims abstract description 11
- 239000012895 dilution Substances 0.000 claims abstract description 11
- 238000002360 preparation method Methods 0.000 claims abstract description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 9
- 229910000033 sodium borohydride Inorganic materials 0.000 claims abstract description 8
- 239000012279 sodium borohydride Substances 0.000 claims abstract description 8
- 229960000583 acetic acid Drugs 0.000 claims abstract description 7
- 238000004108 freeze drying Methods 0.000 claims abstract description 7
- 239000012362 glacial acetic acid Substances 0.000 claims abstract description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 6
- 239000000470 constituent Substances 0.000 claims abstract description 6
- 238000000605 extraction Methods 0.000 claims abstract description 6
- 238000010992 reflux Methods 0.000 claims abstract description 6
- 229920006395 saturated elastomer Polymers 0.000 claims abstract description 6
- 238000003756 stirring Methods 0.000 claims abstract description 6
- 238000006243 chemical reaction Methods 0.000 claims description 6
- 238000013375 chromatographic separation Methods 0.000 claims description 5
- 238000011068 loading method Methods 0.000 claims description 5
- 229910052799 carbon Inorganic materials 0.000 claims description 2
- 150000001875 compounds Chemical class 0.000 claims description 2
- 230000035484 reaction time Effects 0.000 claims 1
- 238000000926 separation method Methods 0.000 abstract description 2
- 238000004440 column chromatography Methods 0.000 abstract 1
- 238000012423 maintenance Methods 0.000 abstract 1
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 8
- 229950009953 etimicin Drugs 0.000 description 4
- 230000000845 anti-microbial effect Effects 0.000 description 3
- OEBISAUVQBGQKC-ZIZSAZPJSA-N (2r,3r,4r,5r)-2-[(1s,2s,3r,4s,6r)-4-amino-3-[(2r,3r,6s)-3-amino-6-(aminomethyl)oxan-2-yl]oxy-6-(ethylamino)-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol;sulfuric acid Chemical compound OS(O)(=O)=O.O([C@@H]1[C@@H](N)C[C@H]([C@@H]([C@H]1O)O[C@@H]1[C@@H]([C@@H](NC)[C@@](C)(O)CO1)O)NCC)[C@H]1O[C@H](CN)CC[C@H]1N OEBISAUVQBGQKC-ZIZSAZPJSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 241000588747 Klebsiella pneumoniae Species 0.000 description 2
- 241000191940 Staphylococcus Species 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 239000002647 aminoglycoside antibiotic agent Substances 0.000 description 2
- VEGXETMJINRLTH-ALRICIOSSA-N etimicin Chemical compound O1C[C@@](O)(C)[C@H](NC)[C@H](O)[C@H]1O[C@@H]1[C@H](O)[C@H](O[C@@H]2[C@@H](CC[C@@H](CN)O2)N)[C@@H](N)C[C@H]1N VEGXETMJINRLTH-ALRICIOSSA-N 0.000 description 2
- DNYGXMICFMACRA-UHFFFAOYSA-N gentamicin C1A Natural products O1C(CNC)CCC(N)C1OC1C(O)C(OC2C(C(NC)C(C)(O)CO2)O)C(N)CC1N DNYGXMICFMACRA-UHFFFAOYSA-N 0.000 description 2
- FFUAGWLWBBFQJT-UHFFFAOYSA-N hexamethyldisilazane Chemical compound C[Si](C)(C)N[Si](C)(C)C FFUAGWLWBBFQJT-UHFFFAOYSA-N 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000006722 reduction reaction Methods 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 241000589291 Acinetobacter Species 0.000 description 1
- DCERHCFNWRGHLK-UHFFFAOYSA-N C[Si](C)C Chemical compound C[Si](C)C DCERHCFNWRGHLK-UHFFFAOYSA-N 0.000 description 1
- JFPVXVDWJQMJEE-QMTHXVAHSA-N Cefuroxime Chemical compound N([C@@H]1C(N2C(=C(COC(N)=O)CS[C@@H]21)C(O)=O)=O)C(=O)C(=NOC)C1=CC=CO1 JFPVXVDWJQMJEE-QMTHXVAHSA-N 0.000 description 1
- 241000588914 Enterobacter Species 0.000 description 1
- 229930182566 Gentamicin Natural products 0.000 description 1
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
- DNYGXMICFMACRA-XHEDQWPISA-N Gentamicin C2b Chemical compound O1[C@H](CNC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N DNYGXMICFMACRA-XHEDQWPISA-N 0.000 description 1
- 241000606768 Haemophilus influenzae Species 0.000 description 1
- RJQXTJLFIWVMTO-TYNCELHUSA-N Methicillin Chemical compound COC1=CC=CC(OC)=C1C(=O)N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@@H]21 RJQXTJLFIWVMTO-TYNCELHUSA-N 0.000 description 1
- 108010087702 Penicillinase Proteins 0.000 description 1
- 241000588770 Proteus mirabilis Species 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 241000607720 Serratia Species 0.000 description 1
- 206010041925 Staphylococcal infections Diseases 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- IKHGUXGNUITLKF-XPULMUKRSA-N acetaldehyde Chemical compound [14CH]([14CH3])=O IKHGUXGNUITLKF-XPULMUKRSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 238000004176 ammonification Methods 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 229960005475 antiinfective agent Drugs 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 229960002518 gentamicin Drugs 0.000 description 1
- VEGXETMJINRLTH-BOZYPMBZSA-N gentamycin C1a Chemical compound O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H](CC[C@@H](CN)O2)N)[C@@H](N)C[C@H]1N VEGXETMJINRLTH-BOZYPMBZSA-N 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 150000002466 imines Chemical class 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 208000015688 methicillin-resistant staphylococcus aureus infectious disease Diseases 0.000 description 1
- 229960003085 meticillin Drugs 0.000 description 1
- 229960004744 micronomicin Drugs 0.000 description 1
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 229950009506 penicillinase Drugs 0.000 description 1
- 230000036470 plasma concentration Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 238000002444 silanisation Methods 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000011287 therapeutic dose Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
Landscapes
- Saccharide Compounds (AREA)
Abstract
本发明涉及一种1-N-乙基庆大霉素C1a的制备方法，该方法包括以下步骤：在温度18-20℃的情况下，将硼氢化钠缓慢加入装有三氯甲烷及冰醋酸的三口烧瓶中，将3,2’,6’-三-N-乙酰基庆大霉素C1a溶解于三氯甲烷中，通过恒压滴液漏斗缓慢加入上述三口烧瓶中，保持温度为40-50℃，剧烈搅拌反应20小时，降温并加入饱和氢氧化钠水溶液中和该体系，乙醇稀释，用三氯甲烷萃取，真空浓缩，所得油状物，加入1N氢氧化钠水溶液回流24小时。无盐水稀释，进行柱层析分离，收集有效成分，浓缩，冻干得产品1-N-乙基庆大霉素C1a。
Description
技术领域
本发明涉及药物化学领域，具体涉及一种氨基糖苷类抗生素药物庆大霉素C1a的衍生物（1-N-乙基庆大霉素C1a）的制备方法。
背景技术
硫酸依替米星(Etimicinsulfate)是我国科研人员自行研制的，拥有自主知识产权的高效、低毒、抗耐药菌的新一代半制备氨基糖苷类抗生素，是唯一获得国家一类新药证书的抗感染药物。其作用机制是抵制敏感菌的正常蛋白制备，对大肠埃希杆菌、克雷伯氏肺炎杆菌、肠杆菌属、沙雷菌属、奇异变形杆菌、沙门菌属、流感嗜血杆菌及葡萄菌属等有较高的抗菌活性，对部分假单胞杆菌、不动杆菌属等具有一定抗菌活性，对部分庆大霉素、小诺霉素和头孢唑啉耐药的金黄色葡萄球菌、大肠埃希杆菌和克雷伯氏肺炎杆菌，其MIC值仍在该产品治疗剂量的血药浓度范围内。对产生青霉素酶的部分葡萄球菌和部分低水平甲氧西林耐药的葡萄球(MRSA)亦有一定的抗菌活性。
依替米星制备过程中需要用到中间体1-N-乙基庆大霉素C1a，现有技术公开了三种制备方法。
中国专利93112412.3描述了以下方法：
将3，2’，6’-三-N-乙酰基庆大霉素C1a用乙醛进行N-乙基化，在用硼氢化钠还原得到3，2’，6’-三-N-乙酰基-1-N-乙基庆大霉素C1a，再用氢氧化钠于100℃回流水解48小时得到1-N-乙基庆大霉素C1a水解溶液，经过分别732强酸性阳离子树脂柱和YPR-Ⅱ大孔树脂柱纯化，得到1-N-乙基庆大霉素C1a。将解析液减压浓缩后加入硫酸，再于60℃用活性炭脱色，最后冻干得到1-N-乙基庆大霉素C1a硫酸盐，重量收率为30%左右。
中国专利201010132962.4,和中国专利201010132963.9对1-N-乙基庆大霉素C1a的制备进行了改进：先用3，2’，6’-三-N-乙酰基庆大霉素C1a与六甲基二硅胺烷在三氯甲烷溶剂中，在浓硫酸的催化作用下加热至回流而发生生成3，2’，6’-三-N-乙酰基-5，2’’，4’’-三（三甲基硅基）庆大霉素C1a的硅烷化反应，直至反应完全。之后再用乙醛进行乙基化。最后重量收率为45%左右。
现行工艺的弊端在于乙醛的氨化还原反应条件对于pH比较敏感，亚胺的中间体不稳定并且整个反应的副反应较多。因此存在收率较低、后期不易分离纯化，工艺过程繁琐的问题。
本发明的优势在于：避开了使用有毒试剂乙醛来进行乙基化的工艺，并且大幅度的提高了反应的收率。
发明内容
本发明之目的是在现有的基础上，提供了一种操作简便，节能环保并能以较高的收率制备依替米星（1-N-乙基庆大霉素C1a）的方法。
实现本发明的技术方案如下：一种1-N-乙基庆大霉素C1a的制备方法，具有以下步骤：
a、在温度18-20℃的条件下，将硼氢化钠缓慢加入装有三氯甲烷及冰醋酸的三口烧瓶中；
b、将3,2’,6’-三-N-乙酰基庆大霉素C1a溶解于三氯甲烷中，通过恒压滴液漏斗缓慢加入上述三口烧瓶中，控制温度，剧烈搅拌至反应完成；
c、降温至室温，加入饱和氢氧化钠水溶液中和该体系。乙醇稀释，三氯甲烷萃取，真空浓缩。所得油状物加入1N氢氧化钠水溶液回流24小时。用无盐水稀释，通入层析分离柱中上样，收集有效成分，浓缩，冻干得目标化合物1-N-乙基庆大霉素C1a。
本发明的有益处在于：避开了使用乙醛乙基化的工艺，并且大幅度的提高了反应的收率。
以下通过比较实验数据进一步说明本发明的有益效果。
具体实施方式
实施例1
在温度18-20℃的情况下，将288g硼氢化钠缓慢加入装有4L三氯甲烷及2L冰醋酸的三口烧瓶中。将575g的3,2’,6’-三-N-乙酰基庆大霉素C1a溶解于6L三氯甲烷中，通过恒压滴液漏斗缓慢加入上述三口烧瓶中，保持温度为40℃，剧烈搅拌反应20小时。降温至25℃，加入饱和氢氧化钠水溶液中和该体系。再加入5L乙醇稀释，用3L三氯甲烷萃取三遍，真空浓缩。所得油状物加入1N氢氧化钠水溶液4L回流24小时。用6L无盐水稀释，通入层析分离柱中上样，无盐水冲洗，乙醇水溶液解析，收集有效成分。浓缩，冻干得产品396g。收率为83%，纯度为94%。
实施例2
在温度18-20℃的情况下，将330g硼氢化钠缓慢加入装有4L三氯甲烷及2L冰醋酸的三口烧瓶中。将575g的3,2’,6’-三-N-乙酰基庆大霉素C1a溶解于6L三氯甲烷中，通过恒压滴液漏斗缓慢加入上述三口烧瓶中，保持温度为50℃，剧烈搅拌反应20小时。降温至25℃，加入饱和氢氧化钠水溶液中和该体系。再加入5L乙醇稀释，用3L三氯甲烷萃取三遍，真空浓缩。所得油状物加入1N氢氧化钠水溶液4L回流24小时。用6L无盐水稀释，通入层析分离柱中上样，无盐水冲洗，乙醇水溶液解析，收集有效成分。浓缩，冻干得产品405g。收率为85%，纯度为95%。
实施例3
在温度18-20℃的情况下，将300g硼氢化钠缓慢加入装有4L三氯甲烷及2L冰醋酸的三口烧瓶中。将575g的3,2’,6’-三-N-乙酰基庆大霉素C1a溶解于6L三氯甲烷中，通过恒压滴液漏斗缓慢加入上述三口烧瓶中，保持温度为45℃，剧烈搅拌反应20小时。降温至25℃，加入饱和氢氧化钠水溶液中和该体系。再加入5L乙醇稀释，用3L三氯甲烷萃取三遍，真空浓缩。所得油状物加入1N氢氧化钠水溶液4L回流24小时。用6L无盐水稀释，通入层析分离柱中上样，无盐水冲洗，乙醇水溶液解析，收集有效成分。浓缩，冻干得产品419g。收率为88%，纯度为96%。
Claims (4)
1.一种1-N-乙基庆大霉素C1a的制备方法，包括以下步骤：
a、在温度18-20℃的条件下，将硼氢化钠缓慢加入装有三氯甲烷及冰醋酸的三口烧瓶中；
b、将3,2’,6’-三-N-乙酰基庆大霉素C1a溶解于三氯甲烷中，通过恒压滴液漏斗缓慢加入上述三口烧瓶中，控制温度，剧烈搅拌至反应完成；
c、降温至室温，加入饱和氢氧化钠水溶液中和该体系，乙醇稀释，三氯甲烷萃取，真空浓缩，所得油状物加入1N氢氧化钠水溶液回流24小时，用无盐水稀释，通入层析分离柱中上样，收集有效成分，浓缩，冻干得目标化合物1-N-乙基庆大霉素C1a。
2.根据权利要求1所述的1-N-乙基庆大霉素C1a的制备方法，其特征是，以3,2’,6’-三-N-乙酰基庆大霉素C1a的量计，硼氢化钠的用量为6-9mol/mol，冰醋酸的用量为25-35mol/mol。
3.根据权利要求1或2所述的1-N-乙基庆大霉素C1a的制备方法，其特征是,滴加3,2’,6’-三-N-乙酰基庆大霉素C1a完毕之后，反应温度控制为0-50℃，反应时间为3-20小时。
4.根据权利要求3所述的1-N-乙基庆大霉素C1a的制备方法，其特征是，反应温度为35-45℃。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310691184.6A CN103665068B (zh) | 2013-12-16 | 2013-12-16 | 一种1-N-乙基庆大霉素C1a的制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310691184.6A CN103665068B (zh) | 2013-12-16 | 2013-12-16 | 一种1-N-乙基庆大霉素C1a的制备方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103665068A CN103665068A (zh) | 2014-03-26 |
| CN103665068B true CN103665068B (zh) | 2016-01-13 |
Family
ID=50303929
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310691184.6A Active CN103665068B (zh) | 2013-12-16 | 2013-12-16 | 一种1-N-乙基庆大霉素C1a的制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103665068B (zh) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108409814A (zh) * | 2018-03-07 | 2018-08-17 | 福安药业集团宁波天衡制药有限公司 | 一种硫酸依替米星的制备方法 |
| CN113185561A (zh) * | 2021-04-24 | 2021-07-30 | 无锡济煜山禾药业股份有限公司 | 一种利用管道反应水解得到1-N-乙基庆大霉素C1a方法 |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1100467A (zh) * | 1993-04-23 | 1995-03-22 | 江苏省微生物研究所 | 1-n-乙基庆大霉素衍生物及其制备方法 |
| EP0546179B1 (en) * | 1990-08-24 | 1997-02-12 | Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai | 4-o-(aminoglycosyl)- or 4,6-di-o-(aminoglycosyl)-2,5-dideoxy-5,5-difluorostreptamine derivative and production thereof |
| CN101928311A (zh) * | 2010-03-26 | 2010-12-29 | 常州方圆制药有限公司 | 1-N-乙基庆大霉素C1a的制备方法 |
| CN101928312A (zh) * | 2010-03-26 | 2010-12-29 | 常州方圆制药有限公司 | 1-N-乙基庆大霉素C1a硫酸盐的制备方法 |
-
2013
- 2013-12-16 CN CN201310691184.6A patent/CN103665068B/zh active Active
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0546179B1 (en) * | 1990-08-24 | 1997-02-12 | Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai | 4-o-(aminoglycosyl)- or 4,6-di-o-(aminoglycosyl)-2,5-dideoxy-5,5-difluorostreptamine derivative and production thereof |
| CN1100467A (zh) * | 1993-04-23 | 1995-03-22 | 江苏省微生物研究所 | 1-n-乙基庆大霉素衍生物及其制备方法 |
| CN101928311A (zh) * | 2010-03-26 | 2010-12-29 | 常州方圆制药有限公司 | 1-N-乙基庆大霉素C1a的制备方法 |
| CN101928312A (zh) * | 2010-03-26 | 2010-12-29 | 常州方圆制药有限公司 | 1-N-乙基庆大霉素C1a硫酸盐的制备方法 |
Non-Patent Citations (1)
| Title |
|---|
| Fluorinated o-Aminophenol Derivatives for Measurement of Intracellular pH;Chung K. Rhee，等;《Bioconjugafe Chem.》;19951231;第6卷(第1期);第78页方案1及第79页右栏第5段 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103665068A (zh) | 2014-03-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105503972B (zh) | 一种以杂多酸为催化剂合成1-N-乙基庆大霉素C1a的方法 | |
| CN102558559B (zh) | 一种连续法合成小分子羟基硅油的方法 | |
| EP1927586B1 (en) | Process for producing 5-aminolevulinic acid hydrochloride | |
| CN105461772A (zh) | 一种曲氟尿苷中间体及曲氟尿苷的制备方法 | |
| CN103665068B (zh) | 一种1-N-乙基庆大霉素C1a的制备方法 | |
| CN103509133B (zh) | 一种香菇多糖快速分离的方法 | |
| CN105524129B (zh) | 一种硫酸依替米星的制备方法 | |
| CN110498823B (zh) | 一种6”-N-乙基庆大霉素C1a的合成方法 | |
| CN111039999A (zh) | 一种依替米星杂质的合成方法 | |
| CN103113430B (zh) | 一种硫酸依替米星的制备方法 | |
| CN101343295B (zh) | 一种从硫酸新霉素发酵液中提取硫酸弗拉菌素的方法 | |
| CN102120738A (zh) | 一种非表型儿茶素单体的制备方法 | |
| CN101805382A (zh) | 一种高纯度奈替米星的分离纯化方法 | |
| CN104311628A (zh) | 一种蛋白溶液细菌内毒素去除方法 | |
| CN102250166A (zh) | 一种依替米星硫酸盐的制备方法 | |
| CN108976263A (zh) | 一种硫酸弗拉菌素的提纯方法 | |
| CN102321100A (zh) | 头孢米诺钠的制备方法 | |
| CN106431901A (zh) | 一种阿尼芬净侧链中间体的制备方法 | |
| CN104926922A (zh) | 匹多莫德的制备方法 | |
| CN110521477B (zh) | 一种提升缙云黄茶1，2，6三没食子酰-β-D-葡萄糖的方法 | |
| CN114349769A (zh) | 一种头孢卡品酯e型异构体的制备方法 | |
| CN103450224A (zh) | 一种头孢噻利δ3异构体的制备方法 | |
| CN102863419A (zh) | 黄烷3-醇乙酰化物及其制备方法和应用 | |
| CN112608350A (zh) | 一种3-n-乙酰基依替米星的合成方法 | |
| CN107739307B (zh) | 一种用稀碱溶液提取-固相萃取柱纯化原儿茶酸的方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CP03 | Change of name, title or address |
Address after: 214028 Changjiang South Road, new Wu District, Wuxi, Jiangsu Province, No. 12 Co-patentee after: JIANGXI JEMINCARE GROUP Co.,Ltd. Patentee after: Wuxi Jiyu Shanhe Pharmaceutical Co.,Ltd. Address before: 214028 No. 12 Changjiang South Road, New District, Jiangsu, Wuxi Co-patentee before: JIANGXI JEMINCARE GROUP Co.,Ltd. Patentee before: WUXI JIMIN KEXIN SHANHE PHARMACEUTICAL Co.,Ltd. |
|
| CP03 | Change of name, title or address | ||
| PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
| PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A preparation method of 1-n-ethyl gentamicin C1A Effective date of registration: 20211223 Granted publication date: 20160113 Pledgee: Bank of China Limited Nanchang Qingyunpu sub branch Pledgor: JIANGXI JEMINCARE GROUP Co.,Ltd. Registration number: Y2021980016166 |
|
| PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20220902 Granted publication date: 20160113 Pledgee: Bank of China Limited Nanchang Qingyunpu sub branch Pledgor: JIANGXI JEMINCARE GROUP Co.,Ltd. Registration number: Y2021980016166 |
|
| PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
| PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A kind of preparation method of 1-N-ethyl gentamicin C1a Effective date of registration: 20220905 Granted publication date: 20160113 Pledgee: Bank of China Limited Nanchang Qingyunpu sub branch Pledgor: JIANGXI JEMINCARE GROUP Co.,Ltd. Registration number: Y2022980014583 |
|
| PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
| PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20230830 Granted publication date: 20160113 Pledgee: Bank of China Limited Nanchang Qingyunpu sub branch Pledgor: JIANGXI JEMINCARE GROUP Co.,Ltd. Registration number: Y2022980014583 |
|
| PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
| PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A preparation method for 1-N-ethylgentamicin C1a Effective date of registration: 20230831 Granted publication date: 20160113 Pledgee: Bank of China Limited Nanchang Qingyunpu sub branch Pledgor: JIANGXI JEMINCARE GROUP Co.,Ltd. Registration number: Y2023980054957 |
|
| PE01 | Entry into force of the registration of the contract for pledge of patent right |